These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 25867727)

  • 1. Apolipoprotein E and neurocognitive function.
    Cullum CM; Weiner MF
    JAMA Neurol; 2015 Apr; 72(4):478. PubMed ID: 25867727
    [No Abstract]   [Full Text] [Related]  

  • 2. Apolipoprotein E and neurocognitive function--in reply.
    Malloy M; Miller B; Kane J
    JAMA Neurol; 2015 Apr; 72(4):479. PubMed ID: 25867729
    [No Abstract]   [Full Text] [Related]  

  • 3. Congenital absence of apolipoprotein E and neurological function.
    Laskowitz DT; Kernagis DN
    JAMA Neurol; 2014 Dec; 71(12):1578-9. PubMed ID: 25486210
    [No Abstract]   [Full Text] [Related]  

  • 4. Congenital absence of apolipoprotein E and neurological function-reply.
    Malloy MJ; Kane JP
    JAMA Neurol; 2014 Dec; 71(12):1579. PubMed ID: 25486213
    [No Abstract]   [Full Text] [Related]  

  • 5. Is apolipoprotein e required for cognitive function in humans?: implications for Alzheimer drug development.
    Lane-Donovan C; Herz J
    JAMA Neurol; 2014 Oct; 71(10):1213-5. PubMed ID: 25110920
    [No Abstract]   [Full Text] [Related]  

  • 6. [Apolipoprotein E phenotyping--useful in the study of hyperlipoproteinemia type III].
    Hagve TA; Furuset T; Christophersen B; Ose L
    Tidsskr Nor Laegeforen; 1993 Mar; 113(7):853-6. PubMed ID: 8480294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E genotyping in Alzheimer's disease.
    Humphries S; Betteridge DJ; Durrington PN; Galton DJ; Nicholls P
    Lancet; 1996 Jun; 347(9017):1776. PubMed ID: 8656945
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel apolipoprotein E2 variant, E2Toranomon (Q187E), identified in a type III hyperlipoproteinemia patient with coronary atherosclerosis.
    Okubo M; Aoyama Y; Harada K; Fukawa M; Tsukada T; Mokuno H; Yamada N; Murase T
    Atherosclerosis; 1998 Sep; 140(1):187-90. PubMed ID: 9733231
    [No Abstract]   [Full Text] [Related]  

  • 9. Unraveling hyperlipidemia type III (dysbetalipoproteinemia), slowly.
    Schaefer JR
    Eur J Hum Genet; 2009 May; 17(5):541-2. PubMed ID: 19034315
    [No Abstract]   [Full Text] [Related]  

  • 10. Apolipoprotein E mutants, hyperlipidemia and arteriosclerosis.
    Utermann G
    Adv Exp Med Biol; 1985; 183():173-88. PubMed ID: 4036699
    [No Abstract]   [Full Text] [Related]  

  • 11. Apolipoprotein EBethesda: a new variant of apolipoprotein E associated with type III hyperlipoproteinemia.
    Gregg RE; Ghiselli G; Brewer HB
    J Clin Endocrinol Metab; 1983 Nov; 57(5):969-74. PubMed ID: 6578216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic abnormalities of plasma apolipoproteins].
    Yamamura T; Yamamoto A
    Rinsho Byori; 1986 Apr; 34(4):408-14. PubMed ID: 3747193
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetics of type III hyperlipoproteinemia.
    Feussner G; Piesch S; Dobmeyer J; Fischer C
    Genet Epidemiol; 1997; 14(3):283-97. PubMed ID: 9181357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Familial hyperlipoproteinemia type III].
    Yamamura T
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1772-7. PubMed ID: 1479217
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hyperlipoproteinemia type III with apolipoprotein E phenotype 2/2].
    Engst R
    Hautarzt; 1985 Nov; 36(11):629-34. PubMed ID: 4077508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restriction isotyping of apolipoprotein E R145C in type III hyperlipoproteinemia.
    Hsia SH; Connelly PW; Hegele RA
    J Investig Med; 1995 Apr; 43(2):187-94. PubMed ID: 7735921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysbetalipoproteinemia and clomipramine.
    Holmes DT; Long P; Frohlich J
    Am J Psychiatry; 2005 Jul; 162(7):1384-5. PubMed ID: 15994726
    [No Abstract]   [Full Text] [Related]  

  • 18. Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemia.
    Evans D; Seedorf U; Beil FU
    Clin Genet; 2005 Oct; 68(4):369-72. PubMed ID: 16143024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic variants of apo E: significance for triglyceride metabolism].
    Mann WA; Brewer HB; Greten H
    Z Gastroenterol Verh; 1991 Mar; 26():106. PubMed ID: 1714116
    [No Abstract]   [Full Text] [Related]  

  • 20. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
    Utermann G
    Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.